22 completed, 9 unknown, 6 terminated, 3 active not recruiting. 47 Phase 2, 8 Phase 1, 5 Phase 3.
Follow Intracerebral Hemorrhage: new trials by email Literature Review of Intracerebral Hemorrhage trials Research Report on Intracerebral Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial Semaglutide, 0.5 mg/mL - Intracerebral Hemorrhage | Phase 2 | Not yet recruiting | Chinese University of Hong Kong | 200 | 2026-06-15 | 2026-05-29 |
| Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. TEP with 18F-DPA-714 injection - Intracerebral Hemorrhage | Phase 2 | Not yet recruiting | University Hospital, Toulouse | 117 | 2026-06-01 | 2026-05-13 |
| Synergistic Minimally Invasive Surgery and Deferoxamine in ICH Minimally Invasive surgery (MIS), Deferoxamine, Standard Medical Care (SMD) - Intracerebral Hemorrhage, ICH - Intracerebral Hemorrhage | Phase 2 / Phase 3 | Not yet recruiting | University of Illinois at Chicago | 240 | 2026-03-01 | 2025-10-10 |
| Stem Cell Therapy for Intracerebral Hemorrhage Device: Phase Ⅰ Dose Level 1, Device: Phase Ⅰ Dose Level 2, Device: Phase Ⅰ Dose Level 3 - Intracerebral Hemorrhage, Mesenchymal Stem Cell | Phase 1 / Phase 2 | Recruiting | Tang Zhouping | 39 | 2025-06-02 | 2026-10-20 |
| Baricitinib for Patients With Intracerebral Hemorrhage Baritinib - Intracerebral Hemorrhage | Phase 2 | Completed | De-zhi Kang | 110 | 2025-01-01 | 2026-06-18 |
| Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial Sirolimus, Starch flake - Cavernous Malformations, Intracerebral Hemorrhage | Phase 2 | Recruiting | Huashan Hospital | 75 | 2024-01-05 | 2024-12-20 |
| Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage HUFF-01 - Intracerebral Hemorrhage | Phase 1 / Phase 2 | Active not recruiting | Hokkaido University Hospital | 8 | 2023-12-01 | 2026-10-15 |
| A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage Ir-CPI - Intracerebral Hemorrhage | Phase 2 | Completed | Bioxodes S.A. | 23 | 2023-11-17 | 2026-07-23 |
| Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage Fingolimod - Intracerebral Hemorrhage | Phase 1 / Phase 2 | Unknown | Tang-Du Hospital | 40 | 2023-10-11 | 2023-10-18 |
| PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE) Propranolol Hydrochloride, control group - Stroke, Vascular Accident | Phase 2 / Phase 3 | Completed | Beijing Tiantan Hospital | 168 | 2023-02-21 | 2025-07-14 |
| Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage Celecoxib 200mg - Intracerebral Hemorrhage | Phase 2 | Recruiting | National Taiwan University Hospital | 60 | 2023-01-01 | 2024-09-20 |
| Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) MW189, Saline - Intracerebral Hemorrhage | Phase 2 | Active not recruiting | Johns Hopkins University | 120 | 2022-10-10 | 2026-04-02 |
| A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage CN-105 - Intracerebral Hemorrhage | Phase 2 | Unknown | Beijing Tiantan Hospital | 240 | 2022-08-24 | 2024-02-13 |
| Studying Anakinra to Reduce Secondary Brain Damage After Spontaneous Haemorrhagic Stroke Anakinra - Intracerebral Hemorrhage | Phase 2 | Unknown | Radboud University Medical Center | 75 | 2022-08-10 | 2024-11-18 |
| Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage Statin - Intracerebral Hemorrhage, Statins | Phase 2 / Phase 3 | Unknown | Capital Medical University | 98 | 2021-08-06 | 2024-01-23 |
| Dimethyl Fumarate for the Treatment of Intracerebral Hemorrhage Dimethyl fumarate, Placebo - Intracerebral Hemorrhage | Phase 2 | Withdrawn | Xuanwu Hospital, Beijing | 2021-06-01 | 2023-10-25 | |
| Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke Spironolactone Pill - Intracerebral Hemorrhage, Ischemic Stroke | Phase 2 | Active not recruiting | Yale University | 160 | 2021-03-19 | 2026-09-04 |
| Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage Edaravone Dexborneol, Placebo - Intracerebral Hemorrhage | Phase 2 | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 390 | 2021-03-01 | 2021-01-19 |
| Normobaric Hyperoxia for Intracerebral Hemorrhage Oxygen storage face masks and nasal catheter, Nasal catheter - Normobaric Hyperoxia, Intracerebral Hemorrhage | Phase 2 | Completed | Capital Medical University | 96 | 2020-01-15 | 2025-04-30 |
| Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2)., 0.9% Sodium-chloride - Intracerebral Hemorrhage | Phase 2 | Completed | National Neuroscience Institute | 60 | 2019-03-24 | 2022-12-01 |
Showing 20 of 47. Sign in to see all of them.
Cerebral Hemorrhage (47) · Stroke (9) · Intracranial Hemorrhages (5) · Hemorrhage (3) · Ischemic Stroke (3) · Brain Injuries, Traumatic (2) · Hemorrhagic Stroke (2) · Hypertension (2) · Hyperthermia (2) · Inflammation (2) · Neuroinflammatory Diseases (2) · Subarachnoid Hemorrhage (2) · Atrial Fibrillation (1) · Brain Edema (1) · Brain Stem Infarctions (1)
Brain Diseases (47) · Cardiovascular Diseases (47) · Central Nervous System Diseases (47) · Nervous System Diseases (47) · Pathologic Processes (47) · Pathological Conditions, Signs and Symptoms (47) · Vascular Diseases (47) · Cerebrovascular Disorders (46) · Hemorrhage (44) · Intracranial Hemorrhages (42) · Signs and Symptoms (4) · Stroke (3) · Wounds and Injuries (3) · Body Temperature Changes (2) · Brain Injuries (2)
Sodium Chloride (5) · Deferoxamine (4) · Labetalol (2) · Minocycline (2) · Saline Solution (2) · Tranexamic Acid (2) · apolipoprotein E mimetic peptide CN-105 (2) · recombinant FVIIa (2) · Acetaminophen (1) · Albumins (1) · Aspirin (1) · Bromocriptine (1) · Celecoxib (1) · Clinical Trials, Phase I as Topic (1) · Contrast Media (1)
Capital Medical University (3) · Beijing Tiantan Hospital (2) · Beth Israel Deaconess Medical Center (2) · Johns Hopkins University (2) · University of Alberta (2) · University of Erlangen-Nürnberg Medical School (2) · AegisCN LLC (1) · AstraZeneca (1) · Augusta University (1) · Bioxodes S.A. (1) · Chinese University of Hong Kong (1) · Daniel Hanley (1) · De-zhi Kang (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1)
United States (17) · China (11) · Canada (7) · Germany (3) · Italy (2) · Belgium (1) · France (1) · Hong Kong (1) · Japan (1) · Mexico (1) · Netherlands (1) · Singapore (1) · Spain (1) · Switzerland (1) · Taiwan (1)
Dimitre Staykov, MD (2) · Magdy Selim, MD, PhD (2) · Alfonso Iorio (1) · Andrew M Naidech, MD MSPH (1) · Antonio M Puppo, MD, PhD (1) · Ashkan Shoamanesh, MD FRCPC (1) · Aurelio Cayuela, MD, PhD (1) · Bonaventure Yiu Ming IP, MB ChB,PhD (1) · Chelsea Kidwell, MD (1) · Daniel F. Hanley, MD (1) · De-zhi Kang, M.D. (1) · Edward C. Jauch, MD, MS (1)
PMID 37870112, PMID 11161595, PMID 11590206, PMID 14671250, PMID 16179504, PMID 16319269, PMID 18289410, PMID 19197830, PMID 20536619, PMID 21346218, PMID 21396235, PMID 23391776, PMID 23551657, PMID 23943316, PMID 24692481, PMID 25005444, PMID 25147326, PMID 25700288, PMID 26067213, PMID 26243227, PMID 26409481, PMID 26451031, PMID 27713572, PMID 27751554, PMID 27758940, PMID 27888608, PMID 27990643, PMID 28101148, PMID 28429734, PMID 28486023, PMID 28525977, PMID 28580533, PMID 28887388, PMID 28928910, PMID 29871521, PMID 30354984, PMID 30739747, PMID 30898550, PMID 31131671, PMID 31424491, PMID 32026447, PMID 32384763, PMID 33499916, PMID 33758069, PMID 33841103, PMID 34789008, PMID 35306827, PMID 35562205, PMID 35676589, PMID 35765072
U01NS074425 (2), 2005 (1), 2025 (1), P50NS044227 (1), P50NS044283 (1), R01AG069930 (1), R01NS046309 (1)